Concomitant Kawasaki Disease and Rotavirus Infection—More Than Just a Coincidence: A Case Report
Abstract
:1. Introduction
2. Materials and Methods
3. Case Report
4. Results
5. Discussion
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lee, W.; Cheah, C.S.; Suhaini, S.A.; Azidin, A.H.; Khoo, M.S.; Ismail, N.A.S.; Ali, A. Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features. Medicina 2022, 58, 734. [Google Scholar] [CrossRef]
- Lee, Y.H. Research trends on causes of Kawasaki disease in the COVID-19 era: Focus on viral infections. Clin. Exp. Pediatr. 2023, 66, 1–11. [Google Scholar] [CrossRef]
- Kumrah, R.; Vignesh, P.; Rawat, A.; Singh, S. Immunogenetics of Kawasaki disease. Clin. Rev. Allergy Immunol. 2020, 59, 122–139. [Google Scholar] [CrossRef] [PubMed]
- Nagata, S. Causes of Kawasaki Disease-From Past to Present. Front. Pediatr. 2019, 7, 18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Prashanth, G.P.; Shivalingam, G. Concomitant Infections Should not Deter Clinicians from Diagnosing Kawasaki Disease. Indian Pediatr. 2016, 53, 1027–1028. [Google Scholar]
- D’Auria, E.; Salvini, F.; Ruscitto, A.; Neri, I.G.; Ballista, P.; Agostoni, C.; Riva, E. A case of Kawasaki disease with anasarca and concomitant rotavirus infection. BMJ Case Rep. 2009, 2009, bcr1020081092. [Google Scholar] [CrossRef] [Green Version]
- Öksüz, B.G.; İğde, M. A Case of a 3-Month-Old Infant with Incomplete Kawasaki Disease After Rotavirus Gastroenteritis. J. Pediatr. Res. 2014, 1, 36–38. [Google Scholar] [CrossRef]
- Kim, D.S. Kawasaki disease. Yonsei Med. J. 2006, 47, 759–772. [Google Scholar] [CrossRef] [Green Version]
- Gkoutzourelas, A.; Bogdanos, D.P.; Sakkas, L.I. Kawasaki Disease and COVID-19. Mediterr. J. Rheumatol. 2020, 31, 268–274. [Google Scholar] [CrossRef]
- Nakamura, A.; Ikeda, K.; Hamaoka, K. Aetiological Significance of Infectious Stimuli in Kawasaki Disease. Front. Pediatr. 2019, 7, 244. [Google Scholar] [CrossRef] [Green Version]
- Noval Rivas, M.; Arditi, M. Kawasaki disease: Pathophysiology and insights from mouse models. Nat. Rev. Rheumatol. 2020, 16, 391–405. [Google Scholar] [CrossRef]
- Elakabawi, K.; Lin, J.; Jiao, F.; Guo, N.; Yuan, Z. Kawasaki Disease: Global Burden and Genetic Background. Cardiol. Res. 2020, 11, 9–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, W.-T.; Juan, Y.-C.; Liu, C.-H.; Yang, Y.-Y.; Chan, K.A. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants. Vaccine 2020, 38, 6299–6303. [Google Scholar] [CrossRef] [PubMed]
- Kamidani, S.; Panagiotakopoulos, L.; Licata, C.; Daley, M.F.; Yih, W.K.; Zerbo, O.; Tseng, H.F.; DeSilva, M.B.; Nelson, J.C.; Groom, H.C.; et al. Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines. Pediatrics 2022, 150, e2022058789. [Google Scholar] [CrossRef]
- Murata, K.; Onoyama, S.; Yamamura, K.; Mizuno, Y.; Furuno, K.; Matsubara, K.; Hatae, K.; Masuda, K.; Nomura, Y.; Ohno, T.; et al. Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan. Vaccines 2021, 9, 839. [Google Scholar] [CrossRef]
- Matsuno, S.; Utagawa, E.; Sugiura, A. Association of rotavirus infection with Kawasaki syndrome. J. Infect. Dis. 1983, 148, 177. [Google Scholar] [CrossRef]
- Terai, M.; Honda, T.; Yasukawa, K.; Higashi, K.; Hamada, H.; Kohno, Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003, 108, 325–330. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, S.J.; Shin, J.I. Inflammation and hyponatremia: An underrecognized condition? Korean J. Pediatr. 2013, 56, 519–522. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Menikou, S.; Langford, P.R.; Levin, M. Kawasaki Disease: The Role of Immune Complexes Revisited. Front. Immunol. 2019, 10, 1156. [Google Scholar] [CrossRef] [Green Version]
- Jones, V.G.; Mills, M.; Suarez, D.; Hogan, C.A.; Yeh, D.; Segal, J.B.; Nguyen, E.L.; Barsh, G.R.; Maskatia, S.; Mathew, R. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp. Pediatr. 2020, 10, 537–540. [Google Scholar] [CrossRef]
- Watanabe, T.; Abe, Y.; Sato, S.; Uehara, Y.; Ikeno, K.; Abe, T. Hyponatremia in Kawasaki disease. Pediatr. Nephrol. 2006, 21, 778–781. [Google Scholar] [CrossRef]
- Kil, H.R. Kawasaki disease and hyponatremia. Korean Circ. J. 2010, 40, 489–490. [Google Scholar] [CrossRef] [Green Version]
- Nakamura, Y.; Yashiro, M.; Uehara, R.; Watanabe, M.; Tajimi, M.; Oki, I.; Ojima, T.; Sonobe, T.; Yanagawa, H. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr. Int. 2004, 46, 33–38. [Google Scholar] [CrossRef]
- Lim, G.W.; Lee, M.; Kim, H.S.; Hong, Y.M.; Sohn, S. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in kawasaki disease. Korean Circ. J. 2010, 40, 507–513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, S.M.; Lin, C.P.; Tsai, J.D.; Chao, Y.H.; Sheu, J.N. The significance of serum and fecal levels of interleukin-6 and interleukin-8 in hospitalized children with acute rotavirus and norovirus gastroenteritis. Pediatr. Neonatol. 2014, 55, 120–126. [Google Scholar] [CrossRef] [Green Version]
- Suzuki, H.; Takeuchi, T.; Minami, T.; Shibuta, S.; Uemura, S.; Yoshikawa, N. Water retention in the acute phase of Kawasaki disease: Relationship between oedema and the development of coronary arterial lesions. Eur. J. Pediatr. 2003, 162, 856–859. [Google Scholar] [CrossRef]
- Chen, C.-Y.; Huang, S.-H.; Chien, K.-J.; Lai, T.-J.; Chang, W.-H.; Hsieh, K.-S.; Weng, K.-P. Reappraisal of VEGF in the Pathogenesis of Kawasaki Disease. Children 2022, 9, 1343. [Google Scholar] [CrossRef] [PubMed]
- Moshage, H.J.; Janssen, J.A.; Franssen, J.H.; Hafkenscheid, J.C.; Yap, S.H. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J. Clin. Investig. 1987, 79, 1635–1641. [Google Scholar] [CrossRef]
- Chaudhary, H.; Nameirakpam, J.; Kumrah, R.; Pandiarajan, V.; Suri, D.; Rawat, A.; Singh, S. Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead. Front. Pediatr. 2019, 7, 242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yan, F.; Pan, B.; Sun, H.; Tian, J.; Li, M. Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis. Front. Pediatr. 2019, 7, 374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheah, C.S.; Lee, W.W.L.; Suhaini, S.A.; Azidin, A.H.; Khoo, M.S.; Ismail, N.A.S.; Ali, A. Kawasaki disease in Malaysia: Biochemical profile, characterization, diagnosis and treatment. Front. Pediatr. 2022, 10, 1090928. [Google Scholar] [CrossRef] [PubMed]
- Broderick, C.; Kobayashi, S.; Suto, M.; Ito, S.; Kobayashi, T. Intravenous immunoglobulin for the treatment of Kawasaki disease. Cochrane Database Syst. Rev. 2021, 2021, Cd014884. [Google Scholar] [CrossRef]
- Shulman, S.T. Intravenous Immunoglobulin for the Treatment of Kawasaki Disease. Pediatr. Ann. 2017, 46, e25–e28. [Google Scholar] [CrossRef]
- Tremoulet, A.H. Adjunctive therapies in Kawasaki disease. Int. J. Rheum. Dis. 2018, 21, 76–79. [Google Scholar] [CrossRef]
- Miyata, K.; Miura, M.; Kaneko, T.; Morikawa, Y.; Sakakibara, H.; Matsushima, T.; Misawa, M.; Takahashi, T.; Nakazawa, M.; Tsuchihashi, T.; et al. Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE. Circ. Cardiovasc. Qual. Outcomes 2021, 14, e007191. [Google Scholar] [CrossRef]
- Fortuna-Reyna, B.; Bainto, E.V.; Ulloa-Gutierrez, R.; Garrido-García, L.M.; Estripeaut, D.; del Águila, O.; Gómez, V.; Faugier-Fuentes, E.; Miño-León, G.; Beltrán, S.; et al. Use of Adjunctive Therapy in Acute Kawasaki Disease in Latin America. Front. Pediatr. 2020, 8, 442. [Google Scholar] [CrossRef] [PubMed]
Our Patient | Prashanth et al. [5] | D’Auria et al. [6] | Öksüz and İğde [7] | |
---|---|---|---|---|
Patient Demographics | ||||
Age | 4 months | 11 months | 4 years | 3 months |
Gender | Female | Male | Male | Female |
Initial Presentation | ||||
Fever | + | + | + | + |
Loose stool | + | + | + | + |
Vomiting | − | + | + | + |
Criteria for KD | ||||
Fever > 5 days | + | + | + | + |
Bilateral conjunctivitis | + | − | − | + |
Oral changes | + | + | − | + |
Extremity changes | + | − | − | − |
Lymphadenopathy | + | + | + | − |
Diffuse maculopapular rash | + | + | − | + |
Management | ||||
Treatment | IVIG 2 g/kg over 12 h and oral acetylsalicylic acid 80 mg/kg |
Our Patient | Prashanth et al. [5] | D’Auria et al. [6] | Öksüz and İğde [7] | |
---|---|---|---|---|
Blood investigations | ||||
Haemoglobin (g/dL) | 10.4 | 9.2 | N/A | 10.7 |
White blood cells (109/L) | 47.2 | 12 | 14.5 | 21.7 |
Neutrophils (109/L) | 43.9 (93%) | (72%) | N/A | (69%) |
Platelet (109/L) | 589 | 750 | N/A | 674 |
CRP (mg/L) | 20.78 | 54 | 133 | 36 |
ESR (mm/h) | N/A | N/A | N/A | 82 |
Sodium (mmol/L) | 125 | N/A | 121 | Normal |
Potassium (mmol/L) | 6.2 | N/A | 4.2 | Normal |
Urea (mmol/L) | 2.2 | N/A | 13 | Normal |
Albumin (g/dL) | 18 | Normal | 44.2 | Normal |
Creatinine (umol/L) | 18 | Normal | 2.23 | Normal |
Bilirubin (umol/L) | 6 | Normal | N/A | Normal |
ALP (IU/L) | 99 | Normal | N/A | Normal |
ALT (IU/L) | 17 | Normal | N/A | Normal |
Microbial Investigation | ||||
Rotavirus antigen | Positive | Positive | Positive | Positive |
Other investigation | ||||
Echocardiography | Right coronary artery ectasia with a diameter of 4 mm. | NAD | Proximal part of the right coronary artery aneurysm with a diameter of 3.9 mm and a generalised dilation of the left coronary artery without pericardial effusion. | Dilatation of the left coronary artery with a diameter of 3.2 mm. Normal right coronary artery. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Khoo, M.S.; Ali, A. Concomitant Kawasaki Disease and Rotavirus Infection—More Than Just a Coincidence: A Case Report. Trop. Med. Infect. Dis. 2023, 8, 388. https://doi.org/10.3390/tropicalmed8080388
Khoo MS, Ali A. Concomitant Kawasaki Disease and Rotavirus Infection—More Than Just a Coincidence: A Case Report. Tropical Medicine and Infectious Disease. 2023; 8(8):388. https://doi.org/10.3390/tropicalmed8080388
Chicago/Turabian StyleKhoo, Mohammad Shukri, and Adli Ali. 2023. "Concomitant Kawasaki Disease and Rotavirus Infection—More Than Just a Coincidence: A Case Report" Tropical Medicine and Infectious Disease 8, no. 8: 388. https://doi.org/10.3390/tropicalmed8080388
APA StyleKhoo, M. S., & Ali, A. (2023). Concomitant Kawasaki Disease and Rotavirus Infection—More Than Just a Coincidence: A Case Report. Tropical Medicine and Infectious Disease, 8(8), 388. https://doi.org/10.3390/tropicalmed8080388